First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia
Version of Record online: 7 SEP 2010
© 2010 The Authors Journal compilation © RCOG 2010 BJOG An International Journal of Obstetrics and Gynaecology
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 117, Issue 11, pages 1384–1389, October 2010
How to Cite
Wortelboer, E., Koster, M., Cuckle, H., Stoutenbeek, P., Schielen, P. and Visser, G. (2010), First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology, 117: 1384–1389. doi: 10.1111/j.1471-0528.2010.02690.x
- Issue online: 7 SEP 2010
- Version of Record online: 7 SEP 2010
- Accepted 25 June 2010.
- 8On intrauterine growth; the significance of prenatal care. Int J Gynaecol Obstet 1970;8:895–912..
- 10Multimarker maternal serum screening for chromosomal abnormalities. In: MilunskiA, editor. Genetic Disorder and the Fetus: Diagnosis, Prevention, and Treatment. Baltimore: Johns Hopkins University Press; 2004. pp. 795–835., .
- 11Principles of screening. In: WaldN, LeckI, editors. Antenatal & Neonatal Screening, 2nd edn. Oxford: Oxford University Press; 2000. pp. 3–22., .
- 17A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9–23., , , , , , et al.
- 18The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008; 21:279–87., , , , , , et al.